San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians


 

Approaches to Treating Diabetes that Reduce CV Events: How Effective Are DPP-4 Inhibitors, GLP1-Receptor Agonists and SGLT-2 Inhibitors in Reducing MACE and Preventing HF Events?

343 views
February 5, 2021
Comments 0
Login to view comments. Click here to Login